144 related articles for article (PubMed ID: 30858238)
41. The anthelmintic triclabendazole and its metabolites inhibit the membrane transporter ABCG2/BCRP.
Barrera B; Otero JA; Egido E; Prieto JG; Seelig A; Álvarez AI; Merino G
Antimicrob Agents Chemother; 2012 Jul; 56(7):3535-43. PubMed ID: 22508302
[TBL] [Abstract][Full Text] [Related]
42. Involvement of breast cancer resistance protein (BCRP/ABCG2) in the secretion of danofloxacin into milk: interaction with ivermectin.
Real R; Egido E; Pérez M; González-Lobato L; Barrera B; Prieto JG; Alvarez AI; Merino G
J Vet Pharmacol Ther; 2011 Aug; 34(4):313-21. PubMed ID: 20950350
[TBL] [Abstract][Full Text] [Related]
43. Role of the Abcg2 transporter in plasma levels and tissue accumulation of the anti-inflammatory tolfenamic acid in mice.
Blanco-Paniagua E; García-Lino AM; García-Mateos D; Álvarez AI; Merino G
Chem Biol Interact; 2021 Aug; 345():109537. PubMed ID: 34062171
[TBL] [Abstract][Full Text] [Related]
44. Comparison of pharmacokinetics and milk elimination of flunixin in healthy cows and cows with mastitis.
Kissell LW; Leavens TL; Baynes RE; Riviere JE; Smith GW
J Am Vet Med Assoc; 2015 Jan; 246(1):118-25. PubMed ID: 25517334
[TBL] [Abstract][Full Text] [Related]
45. The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin.
Merino G; Jonker JW; Wagenaar E; van Herwaarden AE; Schinkel AH
Mol Pharmacol; 2005 May; 67(5):1758-64. PubMed ID: 15709111
[TBL] [Abstract][Full Text] [Related]
46. Plasma pharmacokinetics and milk residues of flunixin and 5-hydroxy flunixin following different routes of administration in dairy cattle.
Kissell LW; Smith GW; Leavens TL; Baynes RE; Wu H; Riviere JE
J Dairy Sci; 2012 Dec; 95(12):7151-7. PubMed ID: 23040013
[TBL] [Abstract][Full Text] [Related]
47. P-glycoprotein and breast cancer resistance protein restrict brigatinib brain accumulation and toxicity, and, alongside CYP3A, limit its oral availability.
Li W; Sparidans RW; Wang Y; Lebre MC; Beijnen JH; Schinkel AH
Pharmacol Res; 2018 Nov; 137():47-55. PubMed ID: 30253203
[TBL] [Abstract][Full Text] [Related]
48. Screening and Confirmatory Analyses of Flunixin in Tissues and Bodily Fluids after Intravenous or Intramuscular Administration to Cull Dairy Cows with or without Lipopolysaccharide Challenge.
Shelver WL; Smith DJ; Tell LA; Baynes RE; Schroeder JW; Riviere JE
J Agric Food Chem; 2016 Jan; 64(1):336-45. PubMed ID: 26695354
[TBL] [Abstract][Full Text] [Related]
49. Stereoselective interaction of pantoprazole with ABCG2. II. In vitro flux analysis.
Wang L; Leggas M; Empey PE; McNamara PJ
Drug Metab Dispos; 2012 May; 40(5):1024-31. PubMed ID: 22355035
[TBL] [Abstract][Full Text] [Related]
50. Effects of two anti-inflammatory drugs on physiologic variables and milk production in cows with endotoxin-induced mastitis.
Wagner SA; Apley MD
Am J Vet Res; 2004 Jan; 65(1):64-8. PubMed ID: 14719704
[TBL] [Abstract][Full Text] [Related]
51. Efficacy of flunixin meglumine for the treatment of endotoxin-induced bovine mastitis.
Anderson KL; Smith AR; Shanks RD; Davis LE; Gustafsson BK
Am J Vet Res; 1986 Jun; 47(6):1366-72. PubMed ID: 3524329
[TBL] [Abstract][Full Text] [Related]
52. Suppression of Canine ATP Binding Cassette ABCB1 in Madin-Darby Canine Kidney Type II Cells Unmasks Human ABCG2-Mediated Efflux of Olaparib.
Song YK; Park JE; Oh Y; Hyung S; Jeong YS; Kim MS; Lee W; Chung SJ
J Pharmacol Exp Ther; 2019 Jan; 368(1):79-87. PubMed ID: 30396915
[TBL] [Abstract][Full Text] [Related]
53. Identification of a missense mutation in the bovine ABCG2 gene with a major effect on the QTL on chromosome 6 affecting milk yield and composition in Holstein cattle.
Cohen-Zinder M; Seroussi E; Larkin DM; Loor JJ; Everts-van der Wind A; Lee JH; Drackley JK; Band MR; Hernandez AG; Shani M; Lewin HA; Weller JI; Ron M
Genome Res; 2005 Jul; 15(7):936-44. PubMed ID: 15998908
[TBL] [Abstract][Full Text] [Related]
54. Interaction of mammary bovine ABCG2 with AFB1 and its metabolites and regulation by PCB 126 in a MDCKII in vitro model.
Manzini L; Halwachs S; Girolami F; Badino P; Honscha W; Nebbia C
J Vet Pharmacol Ther; 2017 Dec; 40(6):591-598. PubMed ID: 28198024
[TBL] [Abstract][Full Text] [Related]
55. The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk.
Jonker JW; Merino G; Musters S; van Herwaarden AE; Bolscher E; Wagenaar E; Mesman E; Dale TC; Schinkel AH
Nat Med; 2005 Feb; 11(2):127-9. PubMed ID: 15685169
[TBL] [Abstract][Full Text] [Related]
56. P-glycoprotein (MDR1/ABCB1) and Breast Cancer Resistance Protein (BCRP/ABCG2) limit brain accumulation of the FLT3 inhibitor quizartinib in mice.
Wang J; Gan C; Retmana IA; Sparidans RW; Li W; Lebre MC; Beijnen JH; Schinkel AH
Int J Pharm; 2019 Feb; 556():172-180. PubMed ID: 30553002
[TBL] [Abstract][Full Text] [Related]
57. ABCG2 modulates chlorothiazide permeability--in vitro-characterization of its interactions.
Beéry E; Rajnai Z; Abonyi T; Makai I; Bánsághi S; Erdő F; Sziráki I; Herédi-Szabó K; Kis E; Jani M; Márki-Zay J; Tóth GK; Krajcsi P
Drug Metab Pharmacokinet; 2012; 27(3):349-53. PubMed ID: 22790065
[TBL] [Abstract][Full Text] [Related]
58. Placental BCRP/ABCG2 Transporter Prevents Fetal Exposure to the Estrogenic Mycotoxin Zearalenone.
Szilagyi JT; Gorczyca L; Brinker A; Buckley B; Laskin JD; Aleksunes LM
Toxicol Sci; 2019 Apr; 168(2):394-404. PubMed ID: 30576553
[TBL] [Abstract][Full Text] [Related]
59. Short communication: Behavioral evaluation of the analgesic effect of flunixin meglumine in lame dairy cows.
Wagner SA; Young JM; Tena JK; Manning BH
J Dairy Sci; 2017 Aug; 100(8):6562-6566. PubMed ID: 28624288
[TBL] [Abstract][Full Text] [Related]
60. Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk.
van Herwaarden AE; Wagenaar E; Karnekamp B; Merino G; Jonker JW; Schinkel AH
Carcinogenesis; 2006 Jan; 27(1):123-30. PubMed ID: 16000399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]